Michael J Fox makes surprise appearance in Bafta, brings people to tears

Michael J Fox, renowned for his iconic role in "Back To The Future" and bravely navigating life with Parkinson's disease, delivered an unexpected and moving moment at the Baftas as he stepped onto the stage to present the coveted best film award.

Despite his ongoing health challenges, the 62-year-old actor emerged in a wheelchair but insisted on rising to his feet at the podium to bestow the honor upon Christopher Nolan's "Oppenheimer".

The audience erupted into a heartfelt standing ovation, and emotions ran high among social media users, many expressing tears of admiration at witnessing Fox's resolute presence.


Diagnosed in the 1990s, Fox has seldom made public appearances, making this moment all the more poignant. While Davis Guggenheim's documentary "Still: A Michael J Fox Movie" contended for best documentary, it was edged out by "20 Days In Mariupol".

Bafta host David Tennant paid tribute to the Canadian-American actor as a "true legend of cinema", underscoring Fox's enduring impact on the industry.

In his address, Fox eloquently described cinema as a transformative force, capable of enriching lives and bridging divides. He emphasized the universal power of film to unite people, regardless of their backgrounds.

"There's a reason why they say movies are magic because movies can change your day. It can change your outlook. Sometimes it can change your life," Fox poignantly remarked.

Social media platforms buzzed with admiration for Fox's appearance, with users praising him as a hero and a beacon of inspiration.

Beyond his acting career, Fox has dedicated himself to advancing Parkinson's research, founding the Michael J Fox Foundation in 2000. The foundation's remarkable efforts have raised over £1.58 billion, illuminating hope for those affected by the disease.

Parkinson's disease, characterized by progressive brain damage over time, impacts thousands in England alone, according to NHS data. Parkinson's UK describes it as one of the fastest-growing neurological conditions globally, underscoring the urgency of continued research and support.